ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Feb 16, 2016
Insider Transaction Report
Form 4
Woosley Raymond L.
Director
Transactions
- Award
Stock Option (right to buy)
2016-02-11+8,000→ 8,000 totalExercise: $3.44Exp: 2026-02-10→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the 2013 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 1, 2016. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.